Literature DB >> 16138365

Prevalence of lymph nodes in the apex of level V: a plea against the necessity to dissect the apex of level V in mucosal head and neck cancer.

Marc Hamoir1, Jatin P Shah, Gauthier Desuter, Vincent Grégoire, Stéphane Ledeghen, Isabelle Plouin-Gaudon, Philippe Rombaux, Birgit Weynand, Benoît Lengelé.   

Abstract

BACKGROUND: We assessed the prevalence of histologically proven normal or invaded lymph nodes in the apex of level V.
METHODS: Seventy neck dissections were performed in 41 patients with mucosal head and neck squamous cell carcinoma (SCC). Fifty-one neck dissections were performed in 30 previously untreated patients (group 1); 19 neck dissections were carried out in 11 patients previously irradiated (group 2).
RESULTS: Pathologic analysis was unable to identify any lymph node in 70% of the apex specimens. In group 1, no lymph nodes were detected in 63%, whereas one or more noninvaded lymph nodes were present in 37%; in group 2, no lymph nodes were identified in 89%, whereas one or more normal lymph nodes were found in 11% (p = .03). Metastatic lymph nodes were never identified.
CONCLUSIONS: The prevalence of lymph nodes in the apex was 30%. No invaded lymph nodes were identified. In addition to anatomic evidence, these results suggest that dissection of the apex is not necessary in mucosal head and neck SCC. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16138365     DOI: 10.1002/hed.20264

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Radical neck dissection: is it still indicated?

Authors:  Marc Hamoir; Carl E Silver; Sandra Schmitz; Robert P Takes; Alessandra Rinaldo; Juan P Rodrigo; K Thomas Robbins; Karen T Pitman; Jesus E Medina; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-30       Impact factor: 2.503

2.  Level IIb Neck Dissection in Oral Cavity Cancers- When Should One Address it..?

Authors:  Jyoti Pralhad Dabholkar; Neeti Madan Kapre
Journal:  Indian J Surg Oncol       Date:  2015-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.